Evaluation of the hydroxylamine tempol-H as an in vivo radioprotector

By Hahn S.M.   Krishna M.C.   DeLuca A.M.   Coffin D.   Mitchell J.B.  

Free Radical Biology and Medicine, Vol. 28, Iss. 6, 2000-03 ,pp. : 953-958

Elsevier

Access to resources Recommend Favorite

Quantitation of Tumor Foci in an Experimental Murine Tumor Model Using Computer-Assisted Video Imaging

By Watts A.M.   Kennedy R.C.  

Analytical Biochemistry, Vol. 256, Iss. 2, 1998-02 ,pp. : 217-219

Elsevier

Access to resources Recommend Favorite

Tempol reduces the therapeutic effect of cyclophosphamide on an experimental tumour model

By Kaledin Vasily   Popova Nelly   Nikolin Valery   Vasilieva Evdokia   Kirilyuk Igor   Grigor'ev Igor  

Free Radical Research, Vol. 43, Iss. 7, 2009-07 ,pp. : 685-690

Informa Healthcare

Access to resources Recommend Favorite

Suppression of Tumor Growth with Recombinant Murine Angiostatin

By Wu Z.   O'Reilly M.S.   Folkman J.   Shing Y.  

Biochemical and Biophysical Research Communications, Vol. 236, Iss. 3, 1997-07 ,pp. : 651-654

Elsevier

Access to resources Recommend Favorite

Preferential radioprotection to DNA of normal tissues by ferulic acid under ex vivo and in vivo conditions in tumor bearing mice

By Maurya Dharmendra   Nair Cherupally  

Molecular and Cellular Biochemistry, Vol. 285, Iss. 1-2, 2006-04 ,pp. : 181-190

Springer Publishing Company

Access to resources Recommend Favorite